What is SKIN's health score?

Beauty Health Co (SKIN) has a TradeApes health score of 40 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is SKIN's estimated fair value?

Based on our 5-year discounted cash flow model, Beauty Health Co's estimated fair value is $5.74 per share, representing a 533.6% upside from the current price. This is a model estimate, not a price target or investment recommendation.

Is SKIN undervalued or overvalued?

Our model currently rates SKIN as Undervalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Get live scores & alerts on your phone

📱 Get the App

2 free score cards remaining

Beauty Health Co (SKIN)

Healthcare Undervalued low weak

$0.91

Updated: 2026-07-16

TradeApes Score

Financial Strength

10 Stressed

Operating Trend

53 Mixed

Relative Value

65 Healthy

Capital Allocation

30 Weak

Risk Management

35 Weak

Est. Fair Value $5.74

DCF Upside +533.6%

Sector Rank #860 of 12233

Key Findings

+ Strong revenue growth — sales up more than 20% year over year

Unlock Full Report →

− High leverage — net debt/EBITDA between 3× and 5×

Unlock Full Report →

Industry Related Stocks

Adagio Medical Holdings, Inc. (ADGM) ADM TRONICS UNLIMITED, INC. (ADMT) AETHLON MEDICAL INC (AEMD) Axe Compute Inc. (AGPU) ALIGN TECHNOLOGY INC (ALGN) ALLURION TECHNOLOGIES, INC. (ALUR)

See all Healthcare stocks →

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.